These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors. Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842 [TBL] [Abstract][Full Text] [Related]
4. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2. Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells. Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286 [TBL] [Abstract][Full Text] [Related]
6. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells. Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337 [No Abstract] [Full Text] [Related]
7. Metformin Suppresses Self-Renewal Ability and Tumorigenicity of Osteosarcoma Stem Cells via Reactive Oxygen Species-Mediated Apoptosis and Autophagy. Zhao B; Luo J; Wang Y; Zhou L; Che J; Wang F; Peng S; Zhang G; Shang P Oxid Med Cell Longev; 2019; 2019():9290728. PubMed ID: 31827709 [TBL] [Abstract][Full Text] [Related]
8. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype. Jiang J; Zhang Y; Chuai S; Wang Z; Zheng D; Xu F; Zhang Y; Li C; Liang Y; Chen Z Oncogene; 2012 Feb; 31(6):671-82. PubMed ID: 21743497 [TBL] [Abstract][Full Text] [Related]
9. Valproic acid suppresses the self-renewal and proliferation of head and neck cancer stem cells. Lee SH; Nam HJ; Kang HJ; Samuels TL; Johnston N; Lim YC Oncol Rep; 2015 Oct; 34(4):2065-71. PubMed ID: 26239260 [TBL] [Abstract][Full Text] [Related]
10. CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma. Lun SW; Cheung ST; Cheung PF; To KF; Woo JK; Choy KW; Chow C; Cheung CC; Chung GT; Cheng AS; Ko CW; Tsao SW; Busson P; Ng MH; Lo KW PLoS One; 2012; 7(12):e52426. PubMed ID: 23285037 [TBL] [Abstract][Full Text] [Related]
11. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers. Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682 [TBL] [Abstract][Full Text] [Related]
12. Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line. Xue Z; Yan H; Li J; Liang S; Cai X; Chen X; Wu Q; Gao L; Wu K; Nie Y; Fan D J Cell Biochem; 2012 Jan; 113(1):302-12. PubMed ID: 21913215 [TBL] [Abstract][Full Text] [Related]
13. CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance. Yoon C; Park DJ; Schmidt B; Thomas NJ; Lee HJ; Kim TS; Janjigian YY; Cohen DJ; Yoon SS Clin Cancer Res; 2014 Aug; 20(15):3974-88. PubMed ID: 24947926 [TBL] [Abstract][Full Text] [Related]
14. Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer. Zhang X; Hua R; Wang X; Huang M; Gan L; Wu Z; Zhang J; Wang H; Cheng Y; Li J; Guo W Oncotarget; 2016 Mar; 7(9):9815-31. PubMed ID: 26769843 [TBL] [Abstract][Full Text] [Related]
15. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44 Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678 [TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitor pantoprazole inhibits the proliferation, self‑renewal and chemoresistance of gastric cancer stem cells via the EMT/β‑catenin pathways. Feng S; Zheng Z; Feng L; Yang L; Chen Z; Lin Y; Gao Y; Chen Y Oncol Rep; 2016 Dec; 36(6):3207-3214. PubMed ID: 27748935 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity. Gatti M; Solari A; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Würth R; Corsaro A; Bajetto A; Ratto A; Ferrari A; Daga A; Barbieri F; Florio T Exp Cell Res; 2018 Feb; 363(1):48-64. PubMed ID: 29305964 [TBL] [Abstract][Full Text] [Related]
18. Identification of gastric cancer stem cells using the cell surface marker CD44. Takaishi S; Okumura T; Tu S; Wang SS; Shibata W; Vigneshwaran R; Gordon SA; Shimada Y; Wang TC Stem Cells; 2009 May; 27(5):1006-20. PubMed ID: 19415765 [TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas. Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606 [TBL] [Abstract][Full Text] [Related]
20. New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate. Cui J; Hollmén M; Li L; Chen Y; Proulx ST; Reker D; Schneider G; Detmar M Oncotarget; 2017 Jan; 8(1):1007-1022. PubMed ID: 27894093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]